Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-Anemia

Erythropoietin-resistant anemia is associated with adverse cardiovascular events in patients with ESRD, but the underlying mechanism remains unclear. Here, we evaluated the role of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA). In 54 patients with advanced CKD, er...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Soc Nephrol
Main Authors: Yokoro, Miyuki, Nakayama, Yosuke, Yamagishi, Sho-ichi, Ando, Ryotaro, Sugiyama, Miki, Ito, Sakuya, Yano, Junko, Taguchi, Kensei, Kaida, Yusuke, Saigusa, Daisuke, Kimoto, Masumi, Abe, Takaaki, Ueda, Seiji, Fukami, Kei
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2017
Assuntos:
Basic Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5576934/
https://ncbi.nlm.nih.gov/pubmed/28600471
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2016111184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados